檢索結果 - Yon‐il Kim
- Showing 1 - 1 results of 1
-
1
Phase I and pharmacokinetic study of sorafenib, an oral multikinase inhibitor, in Japanese patients with advanced refractory solid tumors 由 Hironobu Minami, Kenji Kawada, Hiromichi Ebi, Koichi Kitagawa, Yon‐il Kim, Kazuhiro Araki, Hirofumi Mukai, Makoto Tahara, Hikaru Nakajima, Keiko Nakajima
出版 2008Artigo
相關主題
Adverse effect
Astrobiology
Cancer
Chemotherapy
Gastroenterology
Hepatocellular carcinoma
Internal medicine
Medicine
Oncology
Pancreatic cancer
Pharmacodynamics
Pharmacokinetics
Pharmacology
Phases of clinical research
Physics
Rash
Refractory (planetary science)
Response Evaluation Criteria in Solid Tumors
Sorafenib
Tolerability